Website For Sell👉email  info@aiotechnical.in
Marksans Pharma Share Price Target 2025 2026 2027 2028

Marksans Pharma Share Price Target 2025 2026 2027 2028

Rate this post

Marksans Pharma Ltd, a leading player in the pharmaceutical sector, has been making notable strides in its stock market performance. Recently listed on the stock exchanges, the company’s share price has shown a significant upward trend, attributed to its strong reputation and goodwill earned through years of reliable service and customer trust.

Current Share Price Insights

  • Current Trading Price: The shares of Marksans Pharma Ltd are currently trading at ₹140 INR.
  • Price Fluctuations: The share price has decreased by 0.25% from its previous closing price.
  • Price Range: The trading range for the shares is between ₹138.50 INR and ₹144 INR.
  • Recent Performance: Over the past five days, the share price has increased by 0.11%.
  • Yearly Performance: Compared to the last year, the share price has dropped by 12.10%.

Future Share Price Predictions

  • 2024 Target: ₹154.1 INR
  • 2025 Target: ₹253.54 INR
  • 2026 Target: ₹257.17 INR
  • 2027 Target: ₹279.79 INR
  • 2028 Target: ₹303.56 INR
  • 2029 Target: ₹328.5 INR
  • 2030 Target: ₹354.72 INR

These predictions are based on the company’s historical and current performance on the stock exchange.

Growth Metrics

  • Sales Growth: The company has seen a 9.8% increase in sales over the past year, 15.78% over the last three years, and 24.98% over the last five years.
  • 52-Week Range: The highest share price recorded in the last 52 weeks is ₹179.3 INR, while the lowest is ₹68.5 INR.
  • Pharma Sector Rank: Marksans Pharma Ltd is ranked 74th in the pharmaceutical sector.
  • Future Earnings Growth: Forecasts suggest the company’s earnings will grow by 20.06% annually.
  • Net Profit Increase: The net profit has increased by 31.27% compared to the previous year’s profit.

Marksans Pharma Share Price Target 2024-2030

2024

MonthTarget Price
January154.1
February158.87
March154.1
April151.69
May154.28
June179.27
July179.3
August179.29
September179.31
October219.81
November219.8
December219.82

2025

MonthTarget Price
January235.54
February240.33
March235.55
April233.16
May233.17
June233.14
July233.18
August233.6
September233.21
October233.18
November233.16
December233.15

2026

MonthTarget Price
January257.17
February261.92
March257.16
April254.72
May254.76
June254.8
July254.77
August254.76
September254.73
October254.74
November245.77
December254.75

2027

MonthTarget Price
January279.79
February284.53
March279.73
April277.31
May277.34
June277.36
July277.37
August277.39
September277.41
October277.42
November277.43
December277.4

2028

MonthTarget Price
January303.56
February308.3
March303.51
April301.12
May301.16
June301.21
July301.19
August301.22
September301.24
October301.21
November301.22
December301.21

2029

MonthTarget Price
January328.5
February333.31
March328.53
April326.15
May326.13
June326.15
July326.18
August326.17
September326.21
October326.24
November326.21
December326.21

2030

MonthTarget Price
January354.72
February359.53
March354.75
April352.38
May352.35
June352.34
July352.3
August352.34
September352.37
October352.34
November352.36
December352.35

Marksans Pharma Ltd Financials

  • Market Capitalization Value: ₹3527.88 crores
  • Total Share Capital: ₹45.32 crores
  • Long Term Investments: ₹265.75 crores
  • Short Term Investments: ₹0.54 crores
  • Total Inventories: ₹130.95 crores
  • Long Term Provisions: ₹3.18 crores
  • Short Term Provisions: ₹1.33 crores
  • Total Assets: ₹1344.86 crores
  • Total Contingent Liabilities: ₹9.31 crores
  • Total Revenue: ₹715.69 crores
  • Total Expenses: ₹583.65 crores
  • Finance Costs: ₹3.61 crores
  • Equity Dividend Rate: 50%
  • Asset Turnover Ratio: 0.57%
  • Earnings Yield Ratio: 0.03%
  • Dividend Payout Ratio: 9.88%
  • Inventory Turnover Ratio: 2.89%
  • EPS: 2.35
  • ROCE: 16.11%
  • ROE: 19.31%
  • PE Ratio: 33.13%
  • PB Ratio: 1.95%
  • Dividend Yield Ratio: 0.32%
  • Return on Assets: 7.64%
  • Book Value: ₹26.35 crores

Marksans Pharma Ltd Shareholding Pattern

ShareholdersShare Percentage
Promoters43.85%
FII15.11%
DII1.47%
Public39.58%

Marksans Pharma Ltd Competitors

  • Sun Pharmaceuticals India Ltd
  • Aarti Drugs Ltd
  • Cipla Ltd
  • Natco Pharma
  • Suven Pharma

Points to Consider Before Investing in Marksans Pharma Ltd

  • Check the company’s performance on stock exchanges for the current as well as past years and make a rough comparison.
  • Consider all the risk factors before making any investment and keep them noted in your mind even after the investment.
  • Check the tax implications on the shares and observe the trends of tax percentages as it fluctuates in every financial year.
  • Do not opt for any loans for investment purposes; invest a favorable amount only according to your capabilities.
  • Keep on checking the share prices as they can fluctuate at any point in time.

Conclusion

Marksans Pharma Ltd continues to show robust performance in the stock market, with a promising outlook for future growth. Investors can expect steady growth in share prices, supported by the company’s strong sales and earnings forecasts.

Also read about DDJAY Plots in Sohna (Deen Dayal Jan Awas Yojna

FAQs:

Question: What is the Marksans Pharma share price prediction for 2025?

Answer: The predicted share price for Marksans Pharma in 2025 is 235.54 INR.

Question: What is the Marksans Pharma share price prediction for 2030?

Answer: The predicted share price for Marksans Pharma in 2030 is 372 INR.

Question: What is the Marksans Pharma share price target for 2024?

Answer: The target share price for Marksans Pharma in 2024 is 154.1 INR.

Question: What is the Marksans Pharma share price target for 2026?

Answer: The target share price for Marksans Pharma in 2026 is 257.17 INR.

Question: What is the Marksans Pharma share price target for 2028?

Answer: The target share price for Marksans Pharma in 2028 is 303.56 INR.

Question: What is the Marksans Pharma share price target for 2030?

Answer: The target share price for Marksans Pharma in 2030 is 354.72 INR.

Leave a Comment